These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 3112993

  • 1. Tissue-type plasminogen activator and streptokinase induce platelet hyperaggregability in the rabbit.
    Ohlstein EH, Storer B, Fujita T, Shebuski RJ.
    Thromb Res; 1987 May 15; 46(4):575-85. PubMed ID: 3112993
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Temporal effects of thrombolytic agents on platelet function in vivo and their modulation by prostaglandins.
    Rudd MA, George D, Amarante P, Vaughan DE, Loscalzo J.
    Circ Res; 1990 Nov 15; 67(5):1175-81. PubMed ID: 2146037
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of low-dose tissue plasminogen activator and streptokinase on platelet aggregation.
    Berridge DC, Burgess-Wilson ME, Westby JC, Hopkinson BR, Makin GS.
    Br J Surg; 1989 Oct 15; 76(10):1026-30. PubMed ID: 2513082
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.
    Parise P, Hauert J, Iorio A, Callegari P, Agnelli G.
    J Lab Clin Med; 1995 Feb 15; 125(2):212-21. PubMed ID: 7531212
    [Abstract] [Full Text] [Related]

  • 8. Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383.
    Lynch JJ, Cook JJ, Sitko GR, Holahan MA, Ramjit DR, Mellott MJ, Stranieri MT, Stabilito II, Zhang G, Lynch RJ.
    J Pharmacol Exp Ther; 1995 Jan 15; 272(1):20-32. PubMed ID: 7815334
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Platelet function after in vivo and in vitro treatment with thrombolytic agents.
    Bertolino G, Noris P, Previtali M, Gamba G, Ferrario M, Montani N, Balduini CL.
    Am J Cardiol; 1992 Feb 15; 69(5):457-61. PubMed ID: 1736606
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
    Lam SC, Dieter JP, Strebel LC, Taylor TM, Muscolino G, Feinberg H, Le Breton GC.
    J Pharmacol Exp Ther; 1991 Dec 15; 259(3):1371-8. PubMed ID: 1762085
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A novel platelet-rich arterial thrombosis model in rabbits. Simple, reproducible, and dynamic real-time measurement by using double-opposing inverted-sutures model.
    Shieh SJ, Chiu HY, Shi GY, Wu CM, Wang JC, Chen CH, Wu HL.
    Thromb Res; 2001 Sep 01; 103(5):363-76. PubMed ID: 11553369
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.